7Nov
Webinar

Thursday 7 November

Managing and extracting value from IP – an industry perspective

When and where

Date and time

Start: Thursday 7 November 2024, 12:30 PM

End: Thursday 7 November 2024, 01:30 PM

Event Overview

This webinar will discuss how IP (with a focus on patents) is managed and used by major companies in different sectors operating in the UK, including considerations of defensive, exclusivity and licensing models.  A panel of experienced patent attorneys will discuss the different approaches used in their companies and sectors.
The webinar is expected to be of particular interest to private practice attorneys interested in understanding how the output of their work is used by their clients, as well as to attorneys in industry interested in how other companies and sectors operate in IP.

Audience

All, Members, Non Members

Speakers

Kevin Scott, Philips Intellectual Property & Standards

Kevin Scott, Philips Intellectual Property & Standards

Dr Kevin Scott works for Philips Intellectual Property & Standards, where he leads a global team of licensing professionals in licensing Philips patents to third parties in technical areas including telecommunications (UMTS/LTE/5G) and television. Dr Scott has over 20 years’ experience in licensing standard essential patents (SEPs) to companies large and small and has extensive experience in multinational litigation of SEPs. Before joining the IP profession in 1997, Dr Scott worked at Philips research laboratories in the creation of computer simulation programs.

Dr Scott’s technical background is in electrical engineering (with a PhD from University College London) and physics (with a degree in Natural Sciences from Cambridge University). He is a UK Chartered Patent Attorney and a European Patent Attorney, a Council member of the UK’s IP Federation, and is included as a top practitioner in IAM’s Strategy 300, 2024.

Belinda Gascoyne, IBM EMEA & AP

Belinda Gascoyne, IBM EMEA & AP

Belinda is Senior IP Law Counsel at IBM where she heads up the IP Law teams in Europe, Middle East and Africa (EMEA) and Asia-Pacific (AP), which together provide all aspects of IP Law support for IBM in all geographies outside the Americas. Belinda is a Chartered and European Patent Attorney with a background in Physics and has wide practical experience in drafting, filing and prosecuting patent applications as well as in IP strategy, patent management and copyright issues. Before joining IBM in 2004, Belinda worked in private practice in London.

Belinda is also actively involved in UK and European IP policy matters and is a former President, and a Council member of, the IP Federation, and has been named for several years running by Managing IP as one of its “Corporate IP Stars”.

Dan Wood, MSD

Dan Wood, MSD

Dan joined Merck Sharp & Dohme LLC (MSD) in 2023 as a member of their IP Group and advises on all kinds of issues relating to patents. Prior to joining MSD, Dan worked in private practice for six years as a European Patent Attorney. Dan’s technical background is in chemistry (he holds an MChem from the University of Reading and a PhD from the University of Cambridge) and he works on patents relating to small-molecule pharmaceuticals, antibodies, vaccines, manufacturing processes, and medical devices.

Dr Bobby Mukherjee, CIPA Vice President, BAE Systems plc

Dr Bobby Mukherjee, CIPA Vice President, BAE Systems plc

Dr Bobby Mukherjee, Chief Counsel, IP & Technology Law – BAE Systems plc and Past President (2012-2014) of the IP Federation. He is the Chartered Institute of Patent Attorneys (CIPA) Vice-President, President-elect as of 1 January 2024. He previously served and currently sits on CIPA Council, and chaired the CIPA Internal Governance Committee in its formative stage.

Bobby is a qualified UK and European patent attorney with over 28 years’ experience of IP gained in private practice and at BAE Systems plc. He is currently the Head of IP (2009 -) at BAE Systems plc (a FTSE 30 company), which has one of the largest in-house IP teams in the UK. During Bobby’s IP Federation Presidential term, Bobby played a prominent role, on behalf of Industry, in actively engaging with the Parliamentary stages of the UK IP Bill 2013-2014. This resulted in the UK IP Act 2014, with a positive outcome for Industry. He currently sits on the IP Federation Council and until recently, chaired the IP Federation Trade Working Group. On behalf of the IP Federation, he gave evidence in January 2023 on the Comprehensive and Progressive Agreement for Trans-Pacific Partnership (CPTPP) IP provisions to the influential House of Commons International Trade Select Committee. As a direct result of the IP Federation’s diligent work to which Bobby significantly contributed since 2018, the UK is acceding to CPTPP on terms which do not threaten European Patent Convention membership, and which promote international harmonisation of patent laws, another long-standing IP Federation goal. This is a successful outcome for UK plc, and the wider UK patent profession.

Bobby’s career has mostly been spent in the physics field, obtaining and defending patent protection for new products, processes and services globally. He gained a first degree in Natural Sciences (specialising in Physics) from Cambridge University in 1990, and then a Doctorate Degree (D.Phil.) on High Temperature Superconductors from Oxford University in 1995. He has published various research papers in leading Scientific Journals during that time, and during his work experience at the National Physical Laboratory.

Bobby has been named a Corporate IP Star by Managing Intellectual Property every year since 2015.

He received the Legal 500 UK individual of the Year 2019 award for IP. He has been listed on the IAM Strategy 300: World’s leading IP Strategists (2022 and 2023).

In his spare time, Bobby enjoys spending time with friends and family, travelling, and closely following cricket.

Sarah Palmer, Syngenta

Sarah Palmer, Syngenta

Sarah is a Senior Patent Attorney for Syngenta’s Crop Protection Business and lead attorney for the team in the UK.   An experienced professional who has worked solely in-house for 24 years with Syngenta and legacy companies. During that time she has worked in a variety of technical areas,  providing holistic IP advice relating to the company’s biotechnology-based, chemical and simple mechanical inventions.  She has experience not only in drafting, prosecution  and freedom-to-operate analysis on the global stage, but also in IP portfolio and lifecycle management, IP rights enforcement and multi-jurisdictional litigation.

The event has been added to your basket:

Managing and extracting value from IP – an industry perspective

Proceed to basket

Shopping Basket

No products in the cart.

Are you a CIPA member?

Sign in to your account to register for the event

Forgotten password?

If you are not yet registered or a member of CIPA, please register here

Skip to content